Plasma Biomarker in Amblyopia Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Plasma Biomarker in Amblyopia Patients — Stella

Recruiting

Back to Amblyopia trials

Trial locations(1 site)

China

Zhongshan Ophthalmic Center, Guangzhou, Guangdong

Key details

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Enrollment target

~600 participants

Started

November 2022

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

3 Years – 12 Years

Last updated January 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov